• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Vitamin D and MS: conflicting evidence of clinical benefit

February 27, 2013  

RIS: what are the risk factors for CIS/MS?

February 13, 2013  

The Year in (P)review – MS 2013 – Is the Injectable Era (almost) Over?

January 31, 2013  

RIS: what are the risk factors for CIS/MS?

December 26, 2012  

Neuroprotection: This is your brain on tea

December 5, 2012  

FDA delays review of alemtuzumab

November 7, 2012  

Aubade for Aubagio: FDA approves teriflunomide in RRMS

October 24, 2012  

BG-12: Updated data from phase III studies

August 29, 2012  

What is the optimal dosing of natalizumab?

July 25, 2012  

Breastfeeding not a sustainable therapy

July 11, 2012  
Previous
35
36
37
38
39
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Highlights of EAN 2026 – Part 1 posted on June 30, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions